YVONNE MACKILLOP: Open Payments
NPI 1154615052 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,123 in 155 payments from 22 companies in 2025. Trend: 2023 $918 · 2024 $2,189 · 2025 $3,123
Food & beverage: $3,123
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 22 | $559 |
| Otsuka America Pharmaceutical, Inc. | 16 | $302 |
| Janssen Pharmaceuticals, Inc | 11 | $233 |
| Almatica Pharma LLC | 13 | $225 |
| ABBVIE INC. | 12 | $219 |
| Neurocrine BioSciences, Inc. | 14 | $166 |
| Supernus Pharmaceuticals, Inc. | 3 | $162 |
| Axsome Therapeutics, Inc. | 8 | $162 |
| Teva Pharmaceuticals USA, Inc. | 10 | $159 |
| Neos Therapeutics, LP | 8 | $150 |
Products named: HETLIOZ, REXULTI, LOREEV XR, VRAYLAR, SPRAVATO, FANAPT, INGREZZA, Qelbree.
Industry payments across NC — which companies pay providers there.
